ImmunOs Therapeutics AG leverages its HLA-based technology platform to develop first-in-class therapeutics for the treatment of cancer and autoimmune diseases. The Company´s lead product candidate has the potential to treat multiple types of solid tumors and hematologic malignancies by targeting multiple components of the immune system to activate profound anti-tumor responses. ImmunOs is also developing antibodies to block the activation of specific HLA protein molecules associated with autoimmune diseases.
Location: United States, Indiana, York
Total raised: $89.27M
Investors 6
| Date | Name | Website |
| 07.06.2022 | Lightspeed... | lsvp.com |
| - | Mission Bi... | missionbio... |
| - | MK Venture... | mk-vc.com |
| 08.06.2022 | VentureLab | venturelab... |
| 07.06.2022 | GIMV | gimv.com |
| - | BackBone V... | backbone.v... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.06.2022 | Series B | $74M | Lightspeed... |
| 11.12.2019 | Series A | $15.27M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 20.10.2023 | Early-stage pharmaceutical companies make strides in cancer-... | Schlieren-based biotech startup ImmunOs Therapeutics AG develops HLA-based therapeutics to combat ... | startuptic... |
| 18.01.2023 | Green light for ImmunOs Therapeutics first clinical trial | The Zurich-based startup has identified specific HLA molecules known to activate the immune system... | startuptic... |
| 08.06.2022 | Walmart convenes startups and corporates to work on a dirty ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 07.06.2022 | ImmunOs Therapeutics Raises $74M in Series B Financing | ImmunOs Therapeutics AG, a Schlieren (Zurich Area), Switzerland-based biopharmaceutical company leve... | finsmes.co... |
| 07.06.2022 | ImmunOs Therapeutics Raises $74 Million Series B Financing R... | - New investors Samsara, Lightspeed, Gimv, and Mission BioCapital further strengthen investor base a... | globenewsw... |
| 07.06.2022 | ImmunOs Therapeutics raises $74 Million to fund clinical tri... | ImmunOs Therapeutics has identified specific human leukocyte antigen (HLA) molecules known to acti... | startuptic... |
| 07.06.2022 | ImmunOs Therapeutics raises CHF 71 million in B round | ImmunOs Therapeutics raises CHF 71 million in B round 07.06.2022 09:06, Tracy Woodley linkedIn faceb... | venturelab... |
| 10.01.2022 | Experienced top managers join start-ups | Dirk Klee, currently CEO Wealth Management & Investments of Barclays UK, will take over as Chi... | startuptic... |
| 20.09.2021 | Startups welcome executives aboard | Clever.care – Amy Wilson as Chief Executive Officer Clever.Care is a company that provides technol... | startuptic... |
| 10.12.2019 | ImmunOs Therapeutics Raises CHF 15M in Series A Financing | ImmunOs Therapeutics AG, a Schliren, Switzerland-based bio-technology company and developer of a nex... | finsmes.co... |
Show more